NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Verrica Pharmaceuticals Inc (NASDAQ: VRCA)

 
VRCA Technical Analysis
2
As on 9th Jun 2023 VRCA STOCK Price closed @ 5.94 and we RECOMMEND Buy for LONG-TERM with Stoploss of 5.24 & Strong Sell for SHORT-TERM with Stoploss of 8.48 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VRCASTOCK Price

Open 5.71 Change Price %
High 5.99 1 Day 0.24 4.21
Low 5.69 1 Week 0.19 3.30
Close 5.94 1 Month -0.26 -4.19
Volume 247284 1 Year -3.16 -34.73
52 Week High 9.53 | 52 Week Low 1.81
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
VRCA
Daily Charts
VRCA
Intraday Charts
Whats New @
Bazaartrend
VRCA
Free Analysis
 
VRCA Important Levels Intraday
RESISTANCE6.52
RESISTANCE6.33
RESISTANCE6.22
RESISTANCE6.10
SUPPORT5.78
SUPPORT5.66
SUPPORT5.55
SUPPORT5.36
 
VRCA Forecast May 2024
4th UP Forecast10.93
3rd UP Forecast9.33
2nd UP Forecast8.34
1st UP Forecast7.35
1st DOWN Forecast4.53
2nd DOWN Forecast3.54
3rd DOWN Forecast2.55
4th DOWN Forecast0.95
 
VRCA Weekly Forecast
4th UP Forecast8.27
3rd UP Forecast7.52
2nd UP Forecast7.06
1st UP Forecast6.60
1st DOWN Forecast5.28
2nd DOWN Forecast4.82
3rd DOWN Forecast4.36
4th DOWN Forecast3.61
 
VRCA Forecast2024
4th UP Forecast21.7
3rd UP Forecast16.65
2nd UP Forecast13.52
1st UP Forecast10.4
1st DOWN Forecast1.48
2nd DOWN Forecast-1.64
3rd DOWN Forecast-4.77
4th DOWN Forecast-9.82
 
 
VRCA Other Details
Segment EQ
Market Capital 339531392.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VRCA Address
VRCA
 
VRCA Latest News
 
Your Comments and Response on Verrica Pharmaceuticals Inc
 
VRCA Business Profile
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; which has completed phase II clinical trial for treating common warts; and that is in phase II clinical trial for the treatment of external genital warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania. Address: 44 West Gay Street, West Chester, PA, United States, 19380
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service